Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
02 1Piramal Pharma Limited
01 2Buserelin
01 1Switzerland
02 1Blank
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0024
Start Marketing Date : 2004-03-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-015
Start Marketing Date : 2011-03-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (5g/5g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
91
PharmaCompass offers a list of Buserelin Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Buserelin Acetate manufacturer or Buserelin Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Buserelin Acetate manufacturer or Buserelin Acetate supplier.
PharmaCompass also assists you with knowing the Buserelin Acetate API Price utilized in the formulation of products. Buserelin Acetate API Price is not always fixed or binding as the Buserelin Acetate Price is obtained through a variety of data sources. The Buserelin Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone, including repackagers and relabelers. The FDA regulates (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone supplier is an individual or a company that provides (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone active pharmaceutical ingredient (API) or (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone finished formulations upon request. The (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone suppliers may include (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone API manufacturers, exporters, distributors and traders.
click here to find a list of (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone suppliers with NDC on PharmaCompass.
We have 1 companies offering (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone
Get in contact with the supplier of your choice:
